サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1589016

医薬品分析試験アウトソーシングの世界市場

Pharmaceutical Analytical Testing Outsourcing

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品分析試験アウトソーシングの世界市場
出版日: 2024年11月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品分析試験アウトソーシングの世界市場は2030年までに163億米ドルに達する見込み

2023年に103億米ドルと推定される医薬品分析試験アウトソーシングの世界市場は、2023年から2030年にかけてCAGR 6.8%で成長し、2030年には163億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるバイオ分析試験サービスは、CAGR 8.0%を記録し、分析期間終了時には64億米ドルに達すると予測されます。分析期間中の分析法開発・バリデーションサービス分野の成長率はCAGR 6.8%と推定されます。

米国市場は28億米ドルと推定・中国はCAGR6.2%で成長予測

米国の医薬品分析試験アウトソーシング市場は2023年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 6.2%で推移し、2030年には25億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.5％と5.2％と予測されています。欧州では、ドイツがCAGR 5.3%で成長すると予測されています。

世界の医薬品分析試験アウトソーシング市場- 主要動向と促進要因のまとめ

医薬品分析試験アウトソーシング業界はどのように進化してきたか？

医薬品分析試験アウトソーシング業界は、過去20年の間に大きな進化を遂げてきました。その主な要因は、医薬品開発の複雑化、規制当局の監視、コスト効率化の必要性です。従来、製薬会社は分析試験のほとんどを社内で実施し、研究開発から市場開拓までの医薬品開発の全段階を管理していました。しかし、医薬品パイプラインが複雑化し、規制当局の要求が高まるにつれ、多くの企業がこれらの専門的な試験機能を外部パートナーにアウトソーシングするようになりました。このシフトにより、製薬会社は創薬や商品化といった自社のコアコンピタンスに集中できる一方、分析試験サービスでは医薬品開発業務受託機関（CRO）の専門知識を活用できるようになりました。

今日、アウトソーシングは医薬品の研究開発（R&D）に不可欠な要素となっています。医薬品分析試験には、原料試験、試験法開発、安定性試験、生物分析サービス、製品リリース試験など、幅広いサービスが含まれます。これらのサービスをアウトソーシングすることで、製薬会社は多額の設備投資をすることなく、最先端の技術、高度な機器、規制に関する専門知識を利用できるようになりました。その結果、アウトソーシング市場は飛躍的な成長を遂げ、CROは小規模なバイオテクノロジー企業から大規模な製薬企業まで、それぞれの需要に応える包括的なサービス群を提供しています。

技術の進歩はどのように医薬品分析試験アウトソーシング市場を形成しているか？

技術の進歩は、検査プロセスの精度、効率、スピードを向上させることで、医薬品分析試験アウトソーシング市場の形成に重要な役割を果たしています。この市場を牽引する最も重要な技術革新の一つは、高度な分析機器とハイスループットスクリーニング技術の採用です。液体クロマトグラフィー質量分析（LC-MS）や核磁気共鳴（NMR）分光法などのこれらの機器は、より高い精度とより速い分析時間を提供し、CROが大量のサンプルを迅速かつ正確に処理することを可能にします。これらの技術は、複雑な分子や不純物の同定・定量に特に重要であり、医薬品検査には欠かせないものとなっています。機器に加え、自動化とロボット工学はラボのワークフローに革命をもたらし、より高い効率性とヒューマンエラーの可能性の低減を可能にしました。自動化されたシステムは、サンプル調製、データ収集、分析といった大量の反復作業を管理し、一貫した再現性のある結果を保証することができます。これは、ハイスループット・スクリーニングや安定性試験のように、何千ものサンプルを同時に処理する必要があるような分野で、特に貴重なものとなっています。さらに、クラウドコンピューティングとデータ分析の統合により、製薬会社やCROはデータをより効率的に保存、共有、分析できるようになり、世界チーム間のコラボレーションを合理化し、データインテグリティ規制へのコンプライアンスを確保できるようになりました。

医薬品分析試験のアウトソーシングを促進する主な市場動向とは？

医薬品分析試験のアウトソーシングの成長を後押ししているのは、いくつかの主要な市場動向です。生物製剤とバイオシミラーへの注目の高まりは、高度な分析試験サービスの需要に大きな影響を与えています。生物製剤は、従来の低分子医薬品よりもサイズが大きく複雑であるため、品質、有効性、安全性を確保するために、より厳格で専門的な試験プロトコルが必要となります。生物学的分析試験の専門知識を持つCROは、特に生物製剤に対する規制要件が厳しくなるにつれて、これらの治療法を開発する製薬会社にとって不可欠なパートナーとなっています。市場に影響を与えるもう一つの大きな動向は、医薬品開発における規制当局の監視の高まりです。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関は、医薬品の安全性、品質、有効性に関するガイドラインを厳格化しており、製薬会社は規制遵守や高品質試験の専門知識を提供できるCROを求めるようになっています。これには、不純物、安定性、劣化の試験や、製造工程が適正製造基準（GMP）に準拠していることの確認などが含まれます。特殊医薬品や個別化医薬品の普及も、より専門的な試験サービスの必要性を高めています。個別化治療、特に遺伝学や希少疾病に基づく治療では、多くの場合、非常に特殊な分析法が必要とされますが、多くの製薬企業は自社で実施する能力を持ち合わせていない可能性があります。その結果、製薬会社は医薬品開発のニッチ分野に特化したCROに検査ニーズをアウトソーシングするケースが増えています。さらに、製薬企業が医薬品開発のみに専念し、その他の機能をすべてアウトソーシングするバーチャルファーマモデルへのシフトが、包括的な分析試験サービスに対する需要をさらに加速させています。

医薬品分析試験アウトソーシング市場の成長を促進する主な要因

医薬品分析試験アウトソーシング市場の成長にはいくつかの要因があり、それぞれが外部サービスプロバイダーへの依存を高める要因となっています。主な要因の1つは、特に生物製剤やバイオシミラー医薬品の分野で、医薬品分子が複雑化していることです。これらの医薬品は、その安全性、純度、有効性を保証するために、より高度な分析試験法を必要とし、製薬会社が社内で不足しがちな高度に専門化された機器や専門知識の使用がしばしば必要となります。このため、複雑な生物製剤試験を処理する技術力と規制上のノウハウを有するCROに、これらの業務をアウトソーシングする動きが活発化しています。成長を後押しするもう一つの重要な要因は、アウトソーシングが製薬企業にもたらすコスト削減の可能性です。分析試験をアウトソーシングすることで、企業は高価な機器やインフラへの多額の設備投資を回避することができ、また社内の研究所の人員配置や維持に関連するコストも削減することができます。このことは、社内で試験能力を開発するリソースはないが、新薬候補化合物を開発するために高品質の分析サービスを利用する必要がある、小規模のバイオテクノロジー企業や新興企業にとって特に魅力的です。製薬会社は世界中の規制当局からますます厳しくなる要件に直面しているため、規制当局からの圧力もアウトソーシングの需要を後押ししています。薬事コンプライアンスに精通したCROは、試験プロセスが世界スタンダードに適合していることを保証し、承認プロセスにおける遅延や却下のリスクを軽減することで、明確な優位性を提供します。さらに、医薬品開発の世界化の動向は、製薬企業が複数の地域にまたがって業務を行うことを意味し、それぞれの地域には独自の規制要件が存在します。このため、世界な事業展開と複雑な規制状況を乗り切る能力を持つCROへの依存度がさらに高まっています。最後に、デジタル技術とデータ分析の急速な進歩により、研究開発プロセスの最適化を目指す製薬企業にとって、アウトソーシングは魅力的な選択肢となっています。高度なデータ分析能力を提供するCROは、試験結果に対する深い洞察を提供し、意思決定を迅速化し、医薬品開発全体の効率を向上させることができます。これらの要因と、個別化・専門化された医薬品に対する需要の高まりが相まって、医薬品分析試験アウトソーシング市場は今後も力強い成長を遂げることが確実視されています。

調査対象企業の例（全42件）

  • Bioreliance
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • Dalton Pharma Services
  • Eurofins Scientific
  • Exova
  • Halo Pharma
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • Pharmaceutical Product Development, LLC
  • SGS SA
  • Toxikon, Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22502

Global Pharmaceutical Analytical Testing Outsourcing Market to Reach US$16.3 Billion by 2030

The global market for Pharmaceutical Analytical Testing Outsourcing estimated at US$10.3 Billion in the year 2023, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Bioanalytical Testing Service, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Method Development & Validation Service segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 6.2% CAGR

The Pharmaceutical Analytical Testing Outsourcing market in the U.S. is estimated at US$2.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Pharmaceutical Analytical Testing Outsourcing Market – Key Trends & Drivers Summarized

How Has the Pharmaceutical Analytical Testing Outsourcing Industry Evolved Over Time?

The pharmaceutical analytical testing outsourcing industry has undergone a profound evolution over the past two decades, primarily driven by the increasing complexity of drug development, regulatory scrutiny, and the need for cost efficiencies. Traditionally, pharmaceutical companies conducted most of their analytical testing in-house, managing all stages of drug development from research to market entry. However, as drug pipelines have grown more complex and regulatory demands have increased, many companies have begun outsourcing these specialized testing functions to external partners. This shift allows pharmaceutical companies to focus on their core competencies, such as drug discovery and commercialization, while leveraging the expertise of contract research organizations (CROs) for analytical testing services.

Today, outsourcing has become a vital component of pharmaceutical research and development (R&D). Pharmaceutical analytical testing encompasses a wide range of services including raw material testing, method development, stability testing, bioanalytical services, and product release testing. Outsourcing these services has allowed pharmaceutical companies to access state-of-the-art technology, advanced instrumentation, and regulatory expertise without the need for significant capital investment. As a result, the outsourcing market has grown exponentially, with CROs offering a comprehensive suite of services to meet the demands of both small biotech firms and large pharmaceutical companies alike.

How Are Technological Advancements Shaping the Pharmaceutical Analytical Testing Outsourcing Market?

Technological advancements are playing a critical role in shaping the pharmaceutical analytical testing outsourcing market by improving the accuracy, efficiency, and speed of testing processes. One of the most significant innovations driving this market is the adoption of advanced analytical instruments and high-throughput screening technologies. These instruments, such as liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy, offer higher precision and faster analysis times, enabling CROs to handle large volumes of samples quickly and accurately. These technologies are particularly important for the identification and quantification of complex molecules and impurities, making them indispensable in pharmaceutical testing. In addition to instrumentation, automation and robotics have revolutionized laboratory workflows, allowing for greater efficiency and reducing the chances of human error. Automated systems can manage large volumes of repetitive tasks such as sample preparation, data collection, and analysis, ensuring consistent and reproducible results. This has become particularly valuable in areas like high-throughput screening and stability testing, where thousands of samples may need to be processed simultaneously. Additionally, the integration of cloud computing and data analytics has enabled pharmaceutical companies and CROs to store, share, and analyze data more efficiently, streamlining collaboration across global teams and ensuring compliance with data integrity regulations.

What Are the Key Market Trends Driving Outsourcing in Pharmaceutical Analytical Testing?

Several key market trends are driving the growth of outsourcing in pharmaceutical analytical testing. The increasing focus on biologics and biosimilars has significantly impacted the demand for advanced analytical testing services. Biologics, which are larger and more complex than traditional small-molecule drugs, require more rigorous and specialized testing protocols to ensure quality, efficacy, and safety. CROs with expertise in bioanalytical testing are becoming essential partners for pharmaceutical companies developing these therapies, especially as regulatory requirements for biologics become more stringent. Another major trend influencing the market is the rising regulatory scrutiny in drug development. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are enforcing stricter guidelines on drug safety, quality, and efficacy, prompting pharmaceutical companies to seek out CROs that can provide expertise in regulatory compliance and high-quality testing. This includes testing for impurities, stability, and degradation, as well as ensuring that manufacturing processes adhere to Good Manufacturing Practices (GMP). The increasing prevalence of specialty and personalized medicines is also driving the need for more specialized testing services. Personalized therapies, particularly those based on genetics or rare diseases, often require highly specific analytical methods, which many pharmaceutical companies may not have the in-house capability to perform. As a result, these companies are increasingly outsourcing their testing needs to CROs that specialize in niche areas of drug development. Additionally, the shift toward virtual pharma models, where companies focus exclusively on drug development and outsource all other functions, has further accelerated the demand for comprehensive analytical testing services.

Key Factors Fueling the Growth of the Pharmaceutical Analytical Testing Outsourcing Market

The growth in the pharmaceutical analytical testing outsourcing market is driven by several factors, each contributing to the increasing reliance on external service providers. One of the key drivers is the rising complexity of drug molecules, particularly in the biologics and biosimilars sector. These drugs require more sophisticated analytical testing methods to ensure their safety, purity, and efficacy, which often necessitates the use of highly specialized equipment and expertise that pharmaceutical companies may lack internally. This has prompted the outsourcing of these tasks to CROs that possess the technological capabilities and regulatory know-how to handle complex biologics testing. Another critical factor fueling growth is the cost-saving potential that outsourcing offers pharmaceutical companies. By outsourcing analytical testing, companies can avoid significant capital investment in expensive equipment and infrastructure while also reducing the costs associated with staffing and maintaining in-house laboratories. This is especially appealing to smaller biotech firms or start-ups that may lack the resources to develop in-house testing capabilities but require access to high-quality analytical services to advance their drug candidates. Regulatory pressures are also driving the demand for outsourcing, as pharmaceutical companies face increasingly stringent requirements from regulatory agencies worldwide. CROs with expertise in regulatory compliance offer a distinct advantage by ensuring that testing processes meet global standards, mitigating the risk of delays or rejections during the approval process. Additionally, the growing trend toward globalization in drug development means that pharmaceutical companies are working across multiple geographic regions, each with its own regulatory requirements. This further increases the reliance on CROs that have a global footprint and the ability to navigate complex regulatory landscapes. Lastly, the rapid advancements in digital technologies and data analytics have made outsourcing an attractive option for pharmaceutical companies looking to optimize their R&D processes. CROs that offer advanced data analytics capabilities can provide deeper insights into testing results, accelerating decision-making and improving the overall efficiency of drug development. These factors, combined with the growing demand for personalized and specialized medicines, ensure that the pharmaceutical analytical testing outsourcing market will continue to experience robust growth in the years to come.

Select Competitors (Total 42 Featured) -

  • Bioreliance
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • Dalton Pharma Services
  • Eurofins Scientific
  • Exova
  • Halo Pharma
  • Intertek Group PLC
  • Pace Analytical Services, LLC
  • Pharmaceutical Product Development, LLC
  • SGS SA
  • Toxikon, Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Pharmaceutical Analytical Testing Outsourcing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Complexity of Drug Development and Regulatory Compliance Drives Demand for Outsourced Pharmaceutical Analytical Testing Services
    • Increasing Stringent Regulatory Requirements from Global Health Authorities, Including FDA and EMA, Fuels Growth in Analytical Testing Outsourcing
    • Growing Focus on Cost Efficiency and Speed-to-Market in Drug Development Spurs Demand for Outsourcing Analytical Testing Services
    • Technological Advancements in Analytical Testing, Including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry, Enhance Testing Accuracy
    • Expansion of Biologics and Biosimilars Development Strengthens Demand for Specialized Analytical Testing Outsourcing
    • Increased Adoption of Outsourcing in Emerging Markets Drives Growth of Analytical Testing Services in Asia-Pacific and Latin America
    • Rising Focus on Quality Control and Assurance in Drug Manufacturing Propels Demand for Outsourced Stability and Microbial Testing
    • Growing Need for Advanced Testing Capabilities in Pharmaceutical Packaging, Including Extractables and Leachables Testing
    • Emerging Use of Outsourced Analytical Testing for Preclinical and Clinical Trials Fuels Growth in Early-Stage Drug Development
    • Rising Demand for Analytical Testing Outsourcing in the Development of Personalized Medicine and Gene Therapies
    • Technological Innovations in Automation and AI-Powered Analytical Testing Solutions Enhance Efficiency and Data Accuracy
    • Expansion of Contract Research Organizations (CROs) Offering End-to-End Analytical Testing Services Drives Market Growth
    • Growing Use of Outsourced Analytical Testing in Generic Drug Development and Approval Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Bioanalytical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Bioanalytical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Method Development & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Method Development & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Stability Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Stability Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Pharmaceutical Analytical Testing Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • JAPAN
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 16: Japan Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Japan 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • CHINA
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 18: China Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: China 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • EUROPE
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • FRANCE
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 24: France Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: France 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • GERMANY
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 26: Germany Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Germany 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • ITALY
    • TABLE 28: Italy Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Italy 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 30: UK Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: UK 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Rest of Europe 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Analytical Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Asia-Pacific 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Analytical Testing Outsourcing by Service - Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Rest of World 7-Year Perspective for Pharmaceutical Analytical Testing Outsourcing by Service - Percentage Breakdown of Value Sales for Bioanalytical Testing, Method Development & Validation, Stability Testing and Other Services for the Years 2024 & 2030

IV. COMPETITION